SSIM Wave (ACQUIRED 2022)
SSIMWave’s revolutionary platform was acquired by IMAX in 2022.
As streaming becomes the preferred consumer choice for video content, media and entertainment broadcasters and content producers use SSIMWave’s patented software products to provide the ability to control video quality-of-experience and bandwidth costs in a manner that is unmatched in the industry. The products are based on SSIMWave's video quality-of-experience monitoring technology that won a prime time Engineering Emmy. SSIMWave's products deliver improved video quality-of-experience and reduce bandwidth costs by 50%. Current clients include AMD, ebay, Amazon's Elemental Technologies, Telefonica, Comcast and Rogers.
Nicoya
Nicoya Lifesciences uses nanotechnology to reduce the cost and complexity of scientific instruments, making them accessible to everyone. By using highly sensitive biosensors, these instruments allow scientists to better understand diseases and develop new drugs to treat them. Nicoya Lifesciences was launched in 2012 as a spin-out of the University of Waterloo. Today, their scientific instruments have been used by hundreds of innovative researchers and labs in over 25 countries.
ACTO
ACTO is an AI-powered SaaS platform that combines mobile experiences and engagement data to disrupt how drugs and devices are promoted and brought to market. Global life science companies partner with ACTO to transform their learners’ learning journey and experience at scale. Commercial and clinical leaders leverage ACTO’s Omnichannel Education platform to educate and engage learners across the care continuum through unifiedwww.actoapp.com educational experiences and journeys. Building an ecosystem for life sciences, ACTO holds a network of partnerships with content agencies, data providers, technology companies, and more. ACTO is headquartered in Toronto, with a global team across Canada, the United States, and India. For more information on ACTO for Life Sciences, visit https://acto.com/